Gv Pharma Technologies (Opc) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 28-06-2024
- Paid Up Capital ₹ 50.00 K
as on 28-06-2024
- Company Age 6 Year, 15 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.50 M
as on 28-06-2024
- Revenue 14.14%
(FY 2023)
- Profit 18.49%
(FY 2023)
- Ebitda 171.96%
(FY 2023)
- Net Worth 55.97%
(FY 2023)
- Total Assets 131.79%
(FY 2023)
About Gv Pharma Technologies (Opc)
The Company is engaged in the Engineering Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 50.00 K .
The company currently has active open charges totaling ₹4.50 M.
Gauri Goswami serves as a director at the Company.
- CIN/LLPIN
U51909MH2018OPC317901
- Company No.
317901
- Incorporation Date
06 Dec 2018
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Gv Pharma Technologies (Opc)?
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gauri Goswami  | Director | 06-Dec-2018 | Current |
Financial Performance and Corporate Structure Insights of Gv Pharma Technologies (Opc).
Gv Pharma Technologies (Opc) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.14% increase. The company also saw a substantial improvement in profitability, with a 18.49% increase in profit. The company's net worth Soared by an impressive increase of 55.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gv Pharma Technologies (Opc)?
In 2023, Gv Pharma Technologies (Opc) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Jul 2022 | ₹4.50 M | Open |
How Many Employees Work at Gv Pharma Technologies (Opc)?
Unlock and access historical data on people associated with Gv Pharma Technologies (Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gv Pharma Technologies (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gv Pharma Technologies (Opc)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
